Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Aminophylline in the Bladder to Help Place a Ureteral Stent Quickly

Official title: Intravesical Aminophylline-Assisted Urgent Retrograde Ureteral Stenting for Acute Calculous Anuria: A Prospective Randomized Controlled Trial

Run by Beni-Suef University · NCT07617948 · Data updated 2026-11-12

This study tests whether putting aminophylline into the bladder before stenting helps adults with acute kidney blockage due to stones see if a ureteral stent can be placed more easily and quickly.

More Acute Kidney Injury trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment72 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Banī Suwayf, Beni Suweif Governorate)
StatusRecruiting
StartedApril 8, 2026
Main results expectedMarch 2027
Study endsApril 2027
Registry record updatedJune 2, 2026
Trial IDNCT07617948 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with acute calculous anuria due to ureteral stone obstruction in a solitary functioning kidney or with bilateral obstruction who require urgent decompression.

Probably not a fit

Patients without a favorable anatomy or those who do not respond to aminophylline may see no improvement and could experience standard outcomes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, double-blind trial conducted at Beni-Suef University Hospital. Adults with acute calculous anuria due to ureteral stone obstruction in a solitary kidney or with bilateral obstruction will be assigned to intravesical aminophylline or placebo before attempting retrograde Double-J stent placement. The primary outcome is technical success of stent placement without needing percutaneous nephrostomy; secondary outcomes include stenting time, intraoperative complications, renal function recovery, and postoperative pain. Blinding is maintained by having a nurse prepare the solution and keeping patients and surgeons unaware of group assignment. The trial aims to determine if intravesical aminophylline can facilitate urgent urinary drainage in this emergency setting.

Why it matters

Potential benefit: If successful, the intervention could shorten procedure times and improve the success rate of urgent stent placement in patients with acute obstructive uropathy, potentially preserving kidney function.

How similar studies have gone: This approach is novel for this specific emergency indication, with limited prior data in urgent ureteral stenting using intravesical agents.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged 18 years or older.
2. Diagnosis of acute calculous anuria due to ureteral stone obstruction in a solitary functioning kidney.
3. Obstruction confirmed by pelvi-abdominal ultrasound and computed tomography of the urinary tract.
4. Clinical and laboratory evidence of acute renal impairment, including oliguria or anuria and serum creatinine \>2 mg/dL.
5. Ability to provide written informed consent.

Exclusion Criteria:

1. Known hypersensitivity to aminophylline, theophylline, or other methylxanthines.
2. Evidence of active urinary tract infection or urosepsis.
3. Previous history of ureteral stricture or major urinary tract reconstructive surgery.
4. Hemodynamic instability requiring immediate life-saving measures before urological intervention.
5. Pregnancy.

Where it's running

  • Department of Urology- Beni-Suef University Hospitals
    Banī Suwayf, Beni Suweif Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.